CD24 and ovarian cancer: In lung and ovarian cancer models, targeting CD24 with SWA11 monoclonal antibody effectively delayed the growth of xenografts, reduced blood vessel generation, increased macrophage infiltration of tumor tissue, rendering tumor cells more sensitive to gemcitabine chemotherapy [94,95].